Providing patients with information on pharmacogenetic testing.
This article outlines the key issues to be considered before recommending the use of pharmacogenetic tests, which may predict a patient's response to a particular drug.
Fleeman
Nigel
N
Liverpool Reviews and Implementation Group, University of Liverpool. nigel.fleeman@liverpool.ac.uk
Dickson
Rumona
R
D055317:Evidence-Based Practice; D005817:Genetic Counseling / Q000379:methods*; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D007258:Informed Consent; D010353:Patient Education as Topic / Q000379:methods*; D018579:Patient Selection; D010597:Pharmacogenetics / Q000193:education* / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration